iBio, Inc. (IBIO)
0.7823
+0.01
(+1.77%)
USD |
NASDAQ |
Nov 02, 16:00
0.7853
0.00 (0.00%)
After-Hours: 16:58
iBio Price to Book Value : 0.5083 for Nov. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.4995 |
| October 29, 2026 | 0.5287 |
| October 28, 2026 | 0.5226 |
| October 27, 2026 | 0.4984 |
| October 26, 2026 | 0.4594 |
| October 23, 2026 | 0.4664 |
| October 22, 2026 | 0.5095 |
| October 21, 2026 | 0.5459 |
| October 20, 2026 | 0.5335 |
| October 19, 2026 | 0.4939 |
| October 16, 2026 | 0.498 |
| October 15, 2026 | 0.5087 |
| October 14, 2026 | 0.5074 |
| October 13, 2026 | 0.508 |
| October 12, 2026 | 0.5869 |
| October 09, 2026 | 0.566 |
| October 08, 2026 | 0.5978 |
| October 07, 2026 | 0.6563 |
| October 06, 2026 | 0.6823 |
| October 05, 2026 | 0.7278 |
| October 02, 2026 | 0.7311 |
| October 01, 2026 | 0.7213 |
| September 30, 2026 | 0.7668 |
| September 29, 2026 | 0.7603 |
| September 28, 2026 | 0.7603 |
| Date | Value |
|---|---|
| September 25, 2026 | 0.7733 |
| September 24, 2026 | 0.7798 |
| September 23, 2026 | 0.809 |
| September 22, 2026 | 0.8643 |
| September 21, 2026 | 0.8188 |
| September 18, 2026 | 0.8318 |
| September 17, 2026 | 0.8123 |
| September 16, 2026 | 0.7668 |
| September 15, 2026 | 0.7733 |
| September 14, 2026 | 0.7798 |
| September 11, 2026 | 0.783 |
| September 10, 2026 | 0.796 |
| September 09, 2026 | 0.8188 |
| September 08, 2026 | 0.8448 |
| September 04, 2026 | 0.8513 |
| September 03, 2026 | 0.8448 |
| September 02, 2026 | 0.8513 |
| September 01, 2026 | 0.8188 |
| August 31, 2026 | 0.8253 |
| August 28, 2026 | 0.8838 |
| August 27, 2026 | 0.9098 |
| August 26, 2026 | 0.9293 |
| August 25, 2026 | 0.9552 |
| August 24, 2026 | 0.9228 |
| August 21, 2026 | 0.9293 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.696 |
| Alnylam Pharmaceuticals, Inc. | 5.865 |
| Anika Therapeutics, Inc. | 1.887 |
| Savara, Inc. | 6.756 |
| Vericel Corp. | 5.606 |
Price to Book Value Related Metrics
| PS Ratio | 640.34 |
| Price | 0.7823 |
| Earnings Yield | -57.98% |
| Market Cap | 43.57M |